Finance

Lists
Why is MTNB down 5,10%?
Dive Deeper
MTNB:NYSEAMERICAN
Matinas BioPharma Holdings Inc
USD 2,42
-5,10%
(-0,13) 1D
1 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MTNB...
Open
USD 2,58
High
USD 2,58
Low
USD 2,36
Mkt. cap
2,37 m
Avg. vol.
1,09 m
Volume
43,67 k
52-wk high
USD 29,55
52-wk low
USD 2,26
EPS
-USD 16,39
Beta
2,24
Shares outstanding
980,00 k
No. of employees
2
Open
USD 2,58
High
USD 2,58
Low
USD 2,36
Mkt. cap
2,37 m
Avg. vol.
1,09 m
Volume
43,67 k
52-wk high
USD 29,55
52-wk low
USD 2,26
EPS
-USD 16,39
Beta
2,24
Shares outstanding
980,00 k
No. of employees
2
News stories
From web sources and news partners
About Matinas BioPharma Holdings Inc
CEO-
Employees2
Founded2013
HeadquartersBedminster, New Jersey, Verenigde State van Amerika
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,58 m
1,60 m
1,94 m
1,56 m
Operating expense
1,58 m
1,60 m
1,94 m
1,56 m
Total operating expenses
1,58 m
1,60 m
1,94 m
1,56 m
Operating income
-1,58 m
-1,60 m
-1,94 m
-1,56 m
Other non operating income
45,00 k
-238,00 k
15,00 k
-1,00 k
EBT including unusual items
-1,53 m
-1,91 m
-1,92 m
-1,33 m
EBT excluding unusual items
-1,53 m
-1,84 m
-1,92 m
-1,56 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,53 m
-1,91 m
-1,92 m
-1,33 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-1,00 k
-
-
Net interest expenses
-
-1,00 k
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,58 m
-1,60 m
-1,93 m
-1,55 m
Gain or loss from assets sale
-
73,00 k
-
138,00 k
AI content may include mistakes. Learn more
Google-programme